Key Takeaways
- Iodine is essential for thyroid hormone and early brain development.
- Strong evidence supports repletion when true deficiency is present.
- Usual dose supplementation has limited strong evidence of broad harm.
- Higher intakes can disturb thyroid function in susceptible people.
- Lugol’s solution is a medical iodine form, not routine daily nutrition.
What Iodine Does
Thyroid Hormone
Iodine is a trace mineral the body uses to make thyroid hormone. These hormones help control growth, brain development, body heat, and energy use. The need for iodine rises in pregnancy because the mother must support her own thyroid system and the developing baby’s brain at the same time (Bath and Rayman, 2024).
When Intake Gets Too Low
The strongest evidence on benefit is not vague wellness talk. It is the clear finding that iodine deficiency can impair thyroid function, enlarge the thyroid, and in severe cases harm brain development in children before birth and in early life (Hatch-McChesney and Lieberman, 2022). That part is well established and not controversial.
Food first still makes sense. Seafood, shellfish, eggs, and dairy can provide iodine. Seaweed can also provide a lot, but the amount can swing widely from one serving to the next. That matters because a food that is rich in iodine can also overshoot needs if used carelessly and often.
Where The Strongest Evidence Sits
Deficiency Repletion
High quality human trials support iodine repletion in people who are actually low. In schoolchildren with deficiency, randomized controlled trials found improved cognition after iodine repletion. In one trial from Albania, iodine improved information processing, fine motor skill, and visual problem solving (Zimmermann et al., 2006). In another trial from New Zealand, iodine improved perceptual reasoning in mildly deficient children (Gordon et al., 2009).
That is the kind of evidence that matters. It tests a clear problem, a clear intervention, and a real outcome. It does not prove that everyone should take iodine. It shows that people who are low can benefit from repletion.
Pregnancy
Pregnancy is where public health interest is strongest, but the trial evidence is still incomplete. A 2020 systematic review and meta-analysis found there was not enough good quality evidence to fully support routine iodine supplementation in pregnancy for all women in mildly to moderately deficient settings. That is not proof of no benefit. It means the evidence base is still thinner than many guidelines imply (Dineva et al., 2020).
At the same time, more recent randomized work in mildly deficient pregnant women showed that 150 micrograms per day improved iodine status and lowered thyroglobulin, a marker often used to reflect iodine nutrition and thyroid strain (Manousou et al., 2021).
Another placebo controlled trial reported no appreciable harmful effect on thyroid function from iodine supplementation in mild to moderate deficiency during pregnancy (Censi et al., 2019).
Supplement Use
What Strong Evidence Does Not Show
Iodine supplementation is not dangerous for healthy people when normal amounts are used. That stronger anti-iodine claim usually leans on observational and ecological work, where many things can confuse the result. The best direct human trial evidence does not support a blanket fear message.
The cleanest direct trial on excess is a randomized double-blind study in euthyroid adults. It found that subclinical hypothyroidism appeared in some people when a 400 microgram supplement pushed total intake to about 800 micrograms per day. That is a useful signal. It suggests there is a range where more is not better, and where thyroid function can drift in the wrong direction (Sang et al., 2012).
A second direct trial matters because it looked at people with Hashimoto’s thyroiditis. In that group, 250 micrograms per day of supplemental iodine caused slight but significant changes in thyroid hormone function, and some participants developed thyroid dysfunction. That is real evidence of risk, but it is risk in a predisposed group, not proof that every healthy person should avoid iodine supplements (Reinhardt et al., 1998).
Dose Matters
The evidence fits a dose and context model more than a simple good or bad model.
- Low intake can cause harm.
- Repletion can help when deficiency is present.
- Higher intake can cause problems in some people.
- Thyroid autoimmunity and prior thyroid disease change risk.
This is why strong evidence supports careful use, not panic and not blind enthusiasm.
Lugol’s Iodine Solution
What It Is
Lugol’s solution is the classic mix of iodine and potassium iodide in water. The standard medical formulation is 5 percent iodine and 10 percent potassium iodide (DailyMed, n.d.). This is not just another capsule. It is a concentrated liquid preparation with a long medical history.
What It Has Been Used For
Lugol’s has been used in thyroid care, especially short term in Graves’ disease and before thyroid surgery. The idea is to lower thyroid hormone release and reduce gland blood flow before an operation. A review focused on Lugol’s and other iodide preparations found that it still has a role in that setting, though the study base is not large and many reports are small or retrospective (Calissendorff and Falhammar, 2017).
Short term clinical studies on Lugol’s in hyperthyroid settings suggest it can reduce thyroid hormone levels and is often tolerated over a brief course. In one small rescue treatment study before definitive therapy in uncontrolled Graves’ disease, side effects were limited, and the authors described the treatment as safe in that setting (Calissendorff et al., 2017).
A newer study in toxic nodular goiter also reported that a short course was safe and improved thyroid hormone measures (Hedberg et al., 2024).
What Lugol’s Does Not Prove
Mentioning Lugol’s does not prove that everyone needs a concentrated iodine liquid every day. It proves something narrower. Iodine, even in a strong liquid form, can be used as a tool in specific thyroid settings under clinical supervision. That is very different from saying large daily doses are wise for the general public.
It also means that simple claims that iodine supplementation is obviously dangerous do not fit the direct human evidence. Lugol’s has clear medical use. Risk depends on dose, timing, thyroid status, and why it is being used.
What Strong Evidence Really Supports
A Better Reading Of The Data
The highest-quality evidence supports four practical points. First, iodine is essential, and true deficiency should be corrected. Second, better is not endless. Once intake is adequate, extra iodine does not have strong proof of broad benefit for everyone.
Third, direct evidence of harm from routine standard dose supplementation is limited, not dramatic. Fourth, risk becomes more believable with higher total intake and in people with thyroid autoimmunity or other thyroid disease (Sang et al., 2012; Reinhardt et al., 1998).
Food
The safest long term pattern is usually steady iodine from normal foods, with extra care in pregnancy, low seafood intake, dairy avoidance or other settings where intake may run low. Seaweed can help, but because iodine content varies so much, it is not always a precise tool. Concentrated products, including Lugol’s solution, belong in a more careful category. Before strong claims are made, the best question is not whether iodine is good or bad. The better question is whether the person is likely low, likely replete, or already pushing intake too high.
Before changing your diet, supplements, or health routine, talk with a licensed healthcare professional. For any health concerns or questions about a medical condition, get guidance from a physician or another appropriately trained clinician.
FAQs
Is iodine essential for humans?
Yes. Iodine is required to make thyroid hormone.
Does strong evidence support iodine supplementation for everyone?
No. Strongest support is for correcting true deficiency.
Can standard iodine doses harm healthy adults?
Strong direct evidence for broad harm is limited at standard doses.
Who may react badly to extra iodine?
People with Hashimoto’s, Graves’ disease, or nodular thyroid disease may be more sensitive.
Is Lugol’s solution the same as a basic nutrition supplement?
No. It is a concentrated iodine and iodide liquid with medical uses.
Research
Bath, S.C. and Rayman, M.P. 2024, ‘Thyroid function and iodine intake’, Endocrinology and Metabolism Clinics of North America. Available at: https://pubmed.ncbi.nlm.nih.gov/38693274/
Hatch-McChesney, A. and Lieberman, H.R. 2022, ‘Iodine and iodine deficiency: A comprehensive review of a re-emerging issue’, Nutrients, 14(17), 3474. Available at: https://pubmed.ncbi.nlm.nih.gov/36079737/
Zimmermann, M.B., Connolly, K., Bozo, M., Bridson, J., Rohner, F. and Grimci, L. 2006, ‘Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: A randomized, controlled, double-blind study’, American Journal of Clinical Nutrition, 83(1), pp. 108-114. Available at: https://pubmed.ncbi.nlm.nih.gov/16400058/
Gordon, R.C., Rose, M.C., Skeaff, S.A., Gray, A.R., Morgan, K.M. and Ruffman, T. 2009, ‘Iodine supplementation improves cognition in mildly iodine-deficient children’, American Journal of Clinical Nutrition, 90(5), pp. 1264-1271. Available at: https://pubmed.ncbi.nlm.nih.gov/19726593/
Dineva, M., Fishpool, H., Rayman, M.P., Mendis, J. and Bath, S.C. 2020, ‘Systematic review and meta-analysis of the effects of iodine supplementation in pregnancy on maternal thyroid function and child cognition’, Thyroid, 30(4), pp. 588-602. Available at: https://pubmed.ncbi.nlm.nih.gov/32320029/
Manousou, S., Dahlberg, J., Lindholm, J., Ohman, I., Larsson, A., Chaireti, R., Nyström, H.F. and Wikström, A.K. 2021, ‘A randomized, double-blind study of iodine supplementation during pregnancy in Sweden: pilot evaluation of maternal iodine status and thyroid function’, European Journal of Nutrition, 60(4), pp. 1925-1938. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8354996/
Censi, S., Watutantrige-Fernando, S., Groccia, G., Manso, J., Plebani, M., Faggian, D. and Mian, C. 2019, ‘The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area’, Nutrients, 11(11), 2639. Available at: https://pubmed.ncbi.nlm.nih.gov/31689890/
Sang, Z., Wang, P.P., Yao, Z., Shen, J., Halfyard, B., Tan, L., Zhao, N., Wu, Y., Gao, S., Tan, J., Liu, J., Chen, Z. and Zhang, W. 2012, ‘Exploration of the safe upper level of iodine intake in euthyroid Chinese adults: A randomized double-blind trial’, American Journal of Clinical Nutrition, 95(2), pp. 367-373. Available at: https://pubmed.ncbi.nlm.nih.gov/22205314/
Reinhardt, W., Luster, M., Rudorff, K.H., Heckmann, C., Petrasch, S., Lederbogen, S., Haase, R., Saller, B. and Reiners, C. 1998, ‘Effect of small doses of iodine on thyroid function in patients with Hashimoto’s thyroiditis residing in an area of mild iodine deficiency’, European Journal of Endocrinology, 139(1), pp. 23-28. Available at: https://pubmed.ncbi.nlm.nih.gov/9703374/
DailyMed n.d., ‘LUGOL’S STRONG IODINE, iodine and potassium iodide solution’. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d8f4f37-948c-4740-8e23-2f23e47ebd5b
Calissendorff, J. and Falhammar, H. 2017, ‘Lugol’s solution and other iodide preparations: Perspectives and research directions in Graves’ disease’, Endocrine, 58(3), pp. 467-473. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5693970/
Calissendorff, J., Falhammar, H. and Lundgren, E. 2017, ‘Rescue pre-operative treatment with Lugol’s solution in uncontrolled Graves’ disease’, Endocrine Connections, 6(4), pp. 200-205. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5434745/
Hedberg, F., Ryndin, I., Hallengren, B. and Åsman, P. 2024, ‘Assessing the impact of short-term Lugol’s solution on toxic nodular goiter and toxic adenoma before surgery’, Langenbeck’s Archives of Surgery, 409, 269. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11306062/
